Who owns Obsidian Therapeutics Inc?
- CUSIP Number: 67448a106
Tip: Access positions for across all investors
Analyze quarterly positions in Obsidian Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Obsidian Therapeutics stock
Who bought or sold Obsidian Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Alphabet | 1.2M | $17M | 100% | Sep 2026 |
|
| Geode Capital Management | 483k | $6.6M | 100% | Sep 2026 |
|
| Revelation Capital Management | 428k | $5.9M | 100% | Sep 2026 |
|
| Bank of New York Mellon | 11k | $153k | 100% | Sep 2026 |
|
| Citigroup | 419.00 | $5.8k | 100% | Sep 2026 |
|
| Nuveen | 209.00 | $3.0k | 100% | Sep 2026 |
|
| SBI Securities | 1.00 | $14.000000 | 100% | Sep 2026 |
|
| Danske Bank A/s | 1.00 | $14.000000 | 100% | Sep 2026 |
|